- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Seven Bridges Goes Live With Cancer Genomics Cloud Pilot
Seven Bridges today announced that the system it was selected to develop as part of the National Cancer Institute’s Cloud pilot program is open to researchers worldwide. The Seven Bridges Cancer Genomics Cloud is the first complete ecosystem to give cancer researchers immediate access to one of the world’s largest genomic datasets — The Cancer Genome Atlas (TCGA) — and the computational resources to analyze it.
Seven Bridges today announced that the system it was selected to develop as part of the National Cancer Institute’s Cloud pilot program is open to researchers worldwide. The Seven Bridges Cancer Genomics Cloud is the first complete ecosystem to give cancer researchers immediate access to one of the world’s largest genomic datasets — The Cancer Genome Atlas (TCGA) — and the computational resources to analyze it.
According to the company’s press release:
The Seven Bridges pilot makes more than a petabyte of multi-dimensional data available immediately to researchers, who can also add their own data to analyze alongside TCGA. As an NIH Trusted Partner, Seven Bridges can also authenticate and authorize access to controlled data within TCGA to ensure only NIH-approved researchers may use it.
Dr. Tony Kerlavage, Chief of the Cancer Informatics Branch in the Center for Biomedical Informatics and Information Technology (CBIIT) at the National Cancer Institute commented:
Next-generation sequencing has opened the door to new breakthroughs in precision medicine, but the massive data volumes involved also present significant storage and computing challenges. Our goal is to democratize access to NCI-generated genomic and related data and to create a cost-effective way to provide an analytical framework to the cancer research community.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.